How to build anti-PD1 agonist antibodies

被引：0
|
作者：
Flemming, Alexandra
机构：
[1] Nature Reviews Immunology,
来源：
NATURE REVIEWS IMMUNOLOGY | 2023年 / 23卷 / 03期
关键词：
D O I：
10.1038/s41577-023-00844-2
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
A paper in Science Immunology describes the crucial features of agonist antibodies to the checkpoint molecule PD1.
引用
收藏
页码：139 / 139
页数：1
相关论文
共 50 条
  • [41] Role of time to switch from ipilimumab to anti-PD1 in anti-PD1 efficacy within the French national cohort, MelBase.
    Allayous, Clara
    Dalle, Stephane
    Leccia, Marie Therese
    Aubin, Francois
    Mortier, Laurent
    Marie-Beylot-Barry
    Saiag, Philippe
    Dalac-Rat, Sophie
    Lacour, Jean Philippe
    Maubec, Eve
    Descamps, Vincent
    Guillot, Bernard
    Lesimple, Thierry
    De Quatrebarbes, Julie
    Arnault, Jean-Philippe
    Stoebner, Pierre-Emmanuel
    Porcher, Raphael
    Ballon, Alice
    Oriano, Bastien
    Lebbe, Celeste
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [42] Aggravation of idiopathic Pulmonary Fibrosis during a Therapy with Anti-PD1 Antibodies in a Patient with malignant Melanoma
    Pawlowski, J.
    Moussa, R.
    Nikfarjam, U.
    Dudda, M.
    Mitzel-Rink, H.
    Grabbe, S.
    Loquai, C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2020, 18 : 73 - 73
  • [43] In situimmunization of a TLR9 agonist virus-like particle enhances anti-PD1 therapy
    Cheng, Yinwen
    Lemke-Miltner, Caitlin D.
    Wongpattaraworakul, Wattawan
    Wang, Zhaoming
    Chan, Carlos H. F.
    Salem, Aliasger K.
    Weiner, George J.
    Simons, Andrean L.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [44] Anti-PD1 antibodies in patients aged ≥ 75 years with metastatic melanoma: A retrospective multicentre study
    Ridolfi, Laura
    De Rosa, Francesco
    Petracci, Elisabetta
    Tanda, Enrica Teresa
    Marra, Elena
    Pigozzo, Jacopo
    Marconcini, Riccardo
    Guida, Michele
    Cappellini, Gian Carlo Antonini
    Gallizzi, Giulia
    Occelli, Marcella
    Pala, Laura
    Gambale, Elisabetta
    Bersanelli, Melissa
    Galdo, Giovanna
    Cortellini, Alessio
    Morgese, Francesca
    Zoratto, Federica
    Stucci, Luigia Stefania
    Strippoli, Sabino
    Guidoboni, Massimo
    JOURNAL OF GERIATRIC ONCOLOGY, 2020, 11 (03) : 515 - 522
  • [45] Anti-PD1 antibodies in late elderly advanced melanoma patients: A retrospective multicentre study.
    De Rosa, Francesco
    Ridolfi, Laura
    Tanda, Enrica Teresa
    Marra, Elena
    Pigozzo, Jacopo
    Marconcini, Riccardo
    Guida, Michele
    Gallizzi, Giulia
    Occelli, Marcella
    Pala, Laura
    Gambale, Elisabetta
    Bersanelli, Melissa
    Conca, Raffaele
    Cortellini, Alessio
    Morgese, Francesca
    Zoratto, Federica
    Stucci, Luigia Stefania
    Strippoli, Sabino
    Petracci, Elisabetta
    Guidoboni, Massimo
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [46] Immunomodulating antibodies in the treatment of metastatic melanoma: The experience with anti-CTLA-4, anti-CD137, and anti-PD1
    Simeone, Ester
    Ascierto, Paolo A.
    JOURNAL OF IMMUNOTOXICOLOGY, 2012, 9 (03) : 241 - 247
  • [47] Response to Anti-PD1/L1 Antibodies in Advanced Urothelial Cancer in the 'Real-Life' Setting
    Gadot, Moran
    Arad, Ido
    Atenafu, Eshetu G.
    Levartovsky, Meital
    Portnoy, Orith
    Davidson, Tima
    Schor-Bardach, Rachel
    Berger, Raanan
    Leibowitz, Raya
    PHARMACEUTICALS, 2022, 15 (09)
  • [48] Bispecific anti-PD1 checkpoint inhibitors antibodies (BiCKI), an optimized platform designed to tackle anti-PD-(L)1 primary and secondary resistance mechanisms
    Mary, Caroline
    Morello, Aurore
    Thepenier, Virginie
    Teppaz, Geraldine
    Durand, Justine
    Poirier, Nicolas
    CANCER RESEARCH, 2020, 80 (16)
  • [49] Predicting the response to anti-PD1 therapy in metastatic melanoma
    Heinzerling, Lucie
    Kirchberger, Michael Constantin
    Walter, Lisa
    Schuler, Gerold
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S576 - S579
  • [50] Response to anti-PD1 therapy with nivolumab in metastatic sarcomas
    Paoluzzi, L.
    Cacavio, A.
    Ghesani, M.
    Karambelkar, A.
    Rapkiewicz, A.
    Weber, J.
    Rosen, G.
    CLINICAL SARCOMA RESEARCH, 2016, 6
12345